1McConnell JD,,Roehrborn CG,Bautista OM,et al.The long-term effect of doxazosin,finasteride,and combination therapy on the clinical progression of benign prostatic hyperplasia[].The New England Journal of Medicine.2003
2Jacobsen SJ,Jacobson DJ,Girman CJ,et al.Treatment for benign prostatic hyperplasia among community dwelling men:the Olmsted County study of urinary symptoms and health status[].Journal d Urologie.1999
3McConnell JD,,Bruskewitz R,Walsh P,et al.The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia.Finasteride Long-Term Efficacy and Safety Study Group[].The New England Journal of Medicine.1998
4Lepor H,Williford WO,Barry MJ,et al.The efficacy of terazosin,finasteride,or both in benign prostatic hyperplasia.Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group[].The New England Journal of Medicine.1996
5Djavan B,Nickel JC,de la Rosette J,et al.The urologist view of BPH progression:results of an international survey[].European Urology.2002
6Boyle P,Robertson C,Mazzetta C,et al.The relationship between lower urinary tract symptoms and health status:the UREPIK study[].BJUInt.2003
7Kim CI,Chang HS,Kim BK,et al.Long-term results of medical treatment in benign prostatic hyperplasia[].Urology.2006
8Emberton M,Zinner N,Michel MC,et al.Managing the progression of lower urinary tract symptoms/benign prostatic hyperplasia:therapeutic options for the man at risk[].BJU International.2007
